Showing 23,074 news articles about Government, leadership & policy

Filters Content type: Editors' picks Topic: Government, leadership & policy

The impact of leadership, policy, government and politics on the HIV response. National and international strategies and policies in relation to HIV.

Epidemiology & behaviour

Southern Africa: Geography of an Epidemic

Editor's pick
Incidence 0
11 April 2011
Hepatitis C transmission & prevention

"Promising" results in Oxford trials of Hepatitis C vaccine

Editor's pick
Cherwell
26 November 2014
Hepatitis C transmission & prevention

The Evolution of How Drug Injection Equipment Harbors Hep C

Editor's pick
Hepatitis Central
6 February 2013
Hepatitis C treatment

Vitamin B12 During Hepatitis C Treatment

Editor's pick
Hepatitis Central
22 August 2012
Hepatitis C transmission & prevention

Former Merck Unit Works on First Vaccine for Hepatitis C

Editor's pick
Bloomberg Business Week
22 March 2012
New & experimental hepatitis C treatment

Hepatitis C Phase 3 Trials Underway for TMC435

Editor's pick
Hepatitis Central
13 March 2012
Hepatitis C transmission & prevention

Hepatitis C Survival on Inanimate Objects

Editor's pick
Hepatitis Central
14 February 2012
New & experimental hepatitis C treatment

Next Stage for Biotron's Hep C Drug

Editor's pick
Hepatitis Central
23 March 2011
Hepatitis C treatment

More Support for Genetic Testing of Hepatitis C Patients

Editor's pick
Internal Medicine News
16 March 2011
Hepatitis C treatment

Hepatitis C treatment: Back to the warehouse

Editor's pick
Clinical Liver Disease
26 August 2015
Hepatitis C treatment

Abstracts Have Been Posted: International Liver Congress™ 2015 of the European Association for the Study of the Liver (EASL)

Editor's pick
HCV New Drugs Research
9 April 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
Hepatitis C treatment

Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment

Editor's pick
Hepatitis C News
23 December 2014
Hepatitis C treatment

Will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?

Editor's pick
Hepatitis C New Drugs
10 December 2014
Exposure to HIV through medical procedures

Pakistani Blood Transfusions Spreading Hepatitis, HIV: Official

Editor's pick
HepatitisCNewDrugs
9 December 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
New & experimental hepatitis C treatment

Nucleotide Polymerase Inhibitors - The Search For A Safe Interferon Free Trial

Editor's pick
HCV New Drugs Research
10 January 2013
New & experimental hepatitis C treatment

Hepatitis C - First Interferon-Free Regimens Expected to Launch in 2014 in the United States and Europe

Editor's pick
HCV New Drugs Research
19 December 2012
New & experimental hepatitis C treatment

Monoclonal antibody GS-6624 well tolerated by patients with hepatic fibrosis in initial safety study

Editor's pick
Healio Hepatology
4 December 2012
New & experimental hepatitis C treatment

Bristol-Myers Squibb’s Investigational Hepatitis C Compounds Lambda and Daclatasvir Plus Ribavirin Achieved SVR12 in 93% of Genotype 1b Treatment-Naive Patients In Phase IIb Study

Editor's pick
HCV New Drugs Research
14 November 2012
New & experimental hepatitis C treatment

Gilead May Top Rivals With Hepatitis C Therapy Results

Editor's pick
Bloomberg BusinessWeek
14 November 2012
New & experimental hepatitis C treatment

Abbott Announces Phase 3 Interferon-free Hepatitis C Regimens to be Studied in Broad Patient Populations

Editor's pick
Abbott press release
14 November 2012
Hepatitis C symptoms & diagnosis

Background liver proliferation linked to noncirrhotic HCC in patients with HCV

Editor's pick
Healio Hepatology
13 November 2012
New & experimental hepatitis C treatment

Achillion Provides Update on Clinical HCV Development Programs

Editor's pick
Achillion press release
13 November 2012